Orbital Therapeutics
Biotechnology Research • 
Cambridge, Massachusetts, United States • 51-100 Employees
Company overview
| Headquarters | 100 Binney St, Cambridge, Massachusetts 02142, US |
| Website | |
| NAICS | 541714 |
| Founded | 2022 |
| Employees | 51-100 |
| Socials |
Key Contacts at Orbital Therapeutics
Emrah Ilker Ozay
Director Of Immunology
Kristen Ott
Director Of Rna Sciences
Raghav Poudyal
Associate Director
Benjamin Geilich
Director, Non-Viral Delivery
Tracey Cole
Director, Business Operations
Michelle Murphy
Director Of In Vivo Pharmacology
Sinisa Baranac
Sr. Director, It
Connor Smith
Associate Director, Process Development
Cristina Tan Hehir
Senior Director, Alliance Management
Benjamin Holmes
Director Of Data Sciences
Orbital Therapeutics Email Formats
Orbital Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@orbitaltx.com), used 94.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@orbitaltx.com | 94.6% |
{first initial}{last name} | jdoe@orbitaltx.com | 5.4% |
About Orbital Therapeutics
Orbital Therapeutics is advancing a new generation of RNA medicines designed to reprogram cells in vivo, treating diseases at their source. This approach offers patients a simpler, safer, and more accessible alternative to today’s complex treatments. Built from day one with a fully integrated platform spanning circular and linear RNA, targeted delivery, and AI-guided design, Orbital is working to develop durable, programmable therapies tailored to the distinct biology of each disease. The company’s lead program, OTX-201, targets autoimmune disease through B cell depletion to reset the immune system. Orbital’s platform is built for expansion into broader autoimmune indications, oncology, next-generation vaccines, and protein therapeutics. Led by a team with deep expertise in RNA science, clinical development, and commercialization, Orbital is united by a shared commitment to reach more patients, in more places, with fewer barriers. Learn more at www.orbitaltx.com.
Orbital Therapeutics revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $42,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | $270,000,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Orbital Therapeutics has 31 employees across 7 departments.
Departments
Number of employees
Orbital Therapeutics Tech Stack
Discover the technologies and tools that power Orbital Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
Font scripts
Security
JavaScript libraries
Tag managers
Miscellaneous
Programming languages
Miscellaneous
Blogs
Analytics
JavaScript libraries
United Kingdom
Estonia
India
Chile
Singapore
Spain
Frequently asked questions
4.8
40,000 users
